gallocatechol has been researched along with zidovudine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Bruyne, T; De Clercq, E; Pieters, L; Vanden Berghe, D; Vlietinck, AJ; Witvrouw, M | 1 |
| Hattori, T; Kodama, EN; Li, S | 1 |
2 other study(ies) available for gallocatechol and zidovudine
| Article | Year |
|---|---|
Biological evaluation of proanthocyanidin dimers and related polyphenols.
Topics: Anthocyanins; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Infective Agents; Antiviral Agents; Bacteria; Complement Inactivator Proteins; Euphorbiaceae; Flavonoids; Free Radical Scavengers; Hemolysis; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Peru; Phenols; Plants, Medicinal; Polymers; Simplexvirus | 1999 |
Epigallocatechin gallate inhibits the HIV reverse transcription step.
Topics: Anti-HIV Agents; Catechin; Drug Evaluation, Preclinical; Drug Synergism; HeLa Cells; HIV Infections; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Reverse Transcriptase Inhibitors; Reverse Transcription; Uracil; Zidovudine | 2011 |